| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tempest Therapeutics, Inc. | Director | Stock Option (right to buy) | 1,230 | 27 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TPST | Tempest Therapeutics, Inc. | 27 Jan 2026 | 1 | $0 | 4 | Director | 28 Jan 2026, 16:30 |
| TPST | Tempest Therapeutics, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 18:05 |
| TPST | Tempest Therapeutics, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 20 Jun 2023, 16:50 |
| TPST | Tempest Therapeutics, Inc. | 17 Jun 2022 | 1 | $0 | 4 | Director | 22 Jun 2022, 16:16 |
| TPST | Tempest Therapeutics, Inc. | 01 Jul 2021 | 1 | $0 | 4/A | Director | 20 Sep 2021, 20:34 |